VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
PHG
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
PHGKoninklijke Philips N.V.
$24.97$24.4B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
PHG logo

Koninklijke Philips N.V.

PHG
NYSE · Medical Devices
$24.97
At close - Sep 22, 4:00 PM EDT - USD
Market Cap$24.41B
P/E23.4x
52W High$33.44
Volume568.26K
OverviewTerminalAnalysisFinancialsValuationEarningsBreakoutsOwnership
VCP Research Verdict2026Q2

Margin Recovery Masks Stalled Top-Line Growth

Philips is executing a margin recovery, with gross margin up to 49.3% in 2026Q2 from a trough of 38.9% in 2024Q4, and operating margin reaching 14.0% in the latest quarter. However, revenue growth remains stalled at -1.0% TTM, and the company faces persistent ...

GrowthDecelerating
ProfitabilityStrained
ValuationAttractive
TechnicalsWeak
Explore valuation models
MARKET ACTION

PHG price & volume

Price trend, volume and key moving averages

Launch Terminal
Loading chart...
Decision Checklist4 Core Signals

What matters now

The signals most likely to change the investment case.

01

Earnings momentum

9/12 Beats

EPS beat 9 of last 12 quarters

02

Valuation risk

-27% Peers

P/E is 27% below peer median

03

Market leadership

RS 34 · Lag

Laggard (Underperforming 66% of market)

04

Weak Trend

Below 200DMA

Price < 200DMA

Next CatalystEstimated earnings · Oct 27
01

Build the investment case

Start with the evidence for owning the stock and the risks that can break the thesis.

EXECUTIVE THESIS

The Investment Case

Full Analysis
Fundamental Trajectory

Revenue growth has been flat to negative, with TTM growth at -1.0%, while gross margin improved to 49.3% in 2026Q2 from 38.9% in 2024Q4, but operating margin averaged only 8.4% over the last four quarters, indicating volatile profitability.

Analyst Consensus
Hold(22 analysts)
8 Buy14 Hold0 Sell

The Bull Case

Upside Catalysts

Operational efficiency focus

Philips is viewed positively due to its focus on operational efficiency and profitability improvement, which is expected to drive shareholder value.

Margin recovery potential

The company is undergoing operational simplification and margin recovery, which could enhance its financial performance in the medtech landscape.

Attractive valuation metrics

Philips has a forward P/E ratio of 14.90, suggesting potential undervaluation compared to its trailing P/E of 151.71, indicating improved earnings expectations.

The Bear Case

Key Downside Risks

Market performance

Price History →

Trailing total returns as of 9/23/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).

YTD Return
PHG-4.10%
S&P 500 (^GSPC)+13.20%
1-Year Return
PHG-7.45%
S&P 500 (^GSPC)+15.98%
3-Year Return
PHG+39.84%
S&P 500 (^GSPC)+79.51%
5-Year Return
PHG-32.98%
S&P 500 (^GSPC)+78.10%
02

Test the fundamentals

Check whether operating performance supports the current valuation.

VALUATION & INTRINSIC VALUE

Valuation Scenarios

Valuation Analysis
Trailing P/E5Y Low
23.4x
Forward P/EExpansion
15.2x
EV/EBITDA0th %ile
10.4x
FCF YieldCash Flow
4.2%

Valuation vs 5-Year History

Multiple Range
Metric
Current
5Y Median
Historical Range
Percentile
P/E
23.4x
53.3x
0th· Low
EV/EBITDA
10.4x
19.3x
0th· Low
Price/FCF
23.8x
22.2x
75th· Fair
Current Multiple
5Y Median (50th %ile)

Intrinsic Value Scenarios

DCF Projection
Bear$24.67-1.2%
Base (Fair)$45.61+84.8%
Bull$75.12+200.8%
$24.67 Bear$45.61 Base$75.12 Bull
Current Market Price: $24.97
Trades at a 45.3% discount to Base DCF ($45.61)
Open DCF & Valuation Models →Chart Terminal ↗

Growth & profitability

Annual revenue & EPS trend
Revenue
$17.83B-1.0% YoY
Net income
$895M+227.5% YoY
Free cash flow
$893M-34.1% YoY
Operating margin
8%+5.0 pts YoY
ROIC (TTM)6.4%
Avg ROIC 5Y-
ROE (TTM)7.8%
Piotroski Score7 / 9
Financial Statements →
03

Monitor what changed

Recent results and news deserve attention only when they alter the forward view.

OPERATING RESULTS

Recent Earnings

Earnings History
EPS Beat Rate9/12 (75%)
Revenue Beat Rate7/12 (58%)
QuarterEPS (Act vs Est)Revenue (Act vs Est)
Q3 2026Latest
Jul 27, 2026
$0.57+42.5%
vs $0.40
$5.0B+0.9%
vs $4.9B
Q2 2026
May 6, 2026
$0.27+12.5%
vs $0.24
$4.6B+2.2%
vs $4.5B
Q1 2026
Feb 10, 2026
$0.70+23.9%
vs $0.56
$6.1B+3.1%
vs $5.9B
Q4 2025
Nov 4, 2025
$0.37+0.0%
vs $0.37
$5.0B+0.1%
vs $5.0B
Historical baseline: 12 quarters analyzedGAAP / Adjusted
MARKET COVERAGE

Latest News

5 Stories
PRNewsWire·Sep 15, 2026
Philips OneBlade and Red Bull take self-expression to new heights in Cappadocia, Turkey

In a breathtaking display, Red Bull athlete Marco Waltenspiel and his distinctive moustache achieved a world's first in wingsuit hot-air balloon slalom, soaring between seven hot-air balloons at 200 km/h, to celebrate the freedom to be yourself and follow your passions. AMSTERDAM, Sept.

Business Wire·Sep 8, 2026
Philips Launches Revolutionary Lumea® IPL 9900 Pro: the First At-Home Intense Pulsed Light (IPL) Hair Removal Device With Real-Time Audio Guidance That Talks to You During Treatment

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, this month launched the Philips Lumea IPL 9900 Pro, transforming at-home hair removal into a personalized and rewarding self-care routine. Philips Lumea IPL 9900 Pro is the first at-home IPL with audio feedback and motion guidance that talks to users2, helping give them greater confidence in effective treatment. As the world's no. 1 IPL brand3, Philips brings 25 years of IPL research a.

Zacks Investment Research·Sep 7, 2026
Philips Expands Women's Health Ultrasound Portfolio With New Transducer

PHG broadens women's health ultrasound portfolio with the eV14-2v, offering enhanced imaging, a lighter design and remote collaboration.

Zacks Investment Research·Sep 4, 2026
Philips Shares AI Tool Data for Mitral Regurgitation Assessment at ESC

PHG's AI-powered 3D Auto CFQ shows stronger agreement with cardiac MRI than 2D PISA, supporting its cardiovascular ultrasound strategy.

Filtered for Koninklijke Philips N.V.More Headlines
04

Compare before deciding

Benchmark PHG against direct peers instead of judging its metrics in isolation.

Peers Comparison

Key metrics vs top competitors for Koninklijke Philips N.V. (PHG)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
PHG logoPHGKoninklijke Philips N.V.Current
$24.97$24.41B23.41-1.04%5.02%7.77%1.57%
SYK logoSYKStryker Corporation
$275.07$105.45B32.7511.16%14.43%16.36%—
BSX logoBSXBoston Scientific Corporation
$44.92$66.77B23.1519.87%17.47%14.76%—
EW logoEWEdwards Lifesciences Corporation
$88.78$51.12B48.5111.55%15.43%9.66%—
BAX logoBAXBaxter International Inc.
$23.68$12.23B-13.535.72%-9.27%-16.67%—
ZBH logoZBHZimmer Biomet Holdings, Inc.
$93.98$18.18B26.477.2%9.48%6.36%—

Compare PHG vs Peers

Koninklijke Philips N.V. (PHG) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs SYK

Most directly comparable listed peer for PHG.

Scale Benchmark

vs GE

Larger-name benchmark to compare PHG against a more recognizable public peer.

Peer Set

Compare Top 5

vs SYK, BSX, EW, BAX

Get notified when PHG posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

PHG Frequently Asked Questions

Koninklijke Philips N.V. (PHG) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Koninklijke Philips N.V.'s revenue?

Koninklijke Philips N.V. (PHG) reported $17.66B in revenue for fiscal year 2025. This represents a 45% decrease from $31.92B in 1996.

How fast is Koninklijke Philips N.V. growing?

Koninklijke Philips N.V. (PHG) saw revenue decline by 1.0% over the past year.

Is PHG profitable?

Yes, Koninklijke Philips N.V. (PHG) is profitable, generating $1.11B in net income for fiscal year 2025 (5.0% net margin).

Dividend & Returns
Does PHG pay dividends?

Yes, Koninklijke Philips N.V. (PHG) pays a dividend with a yield of 1.57%. This makes it attractive for income-focused investors.

What is PHG's return on equity?

Koninklijke Philips N.V. (PHG) has a return on equity (ROE) of 7.8%. This is below average, suggesting room for improvement.

What is Koninklijke Philips N.V.'s free cash flow?

Koninklijke Philips N.V. (PHG) generated $1.90B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in PHG back in 1996?

Total return calculator · dividends reinvested · 30+ years of data

See returns →